Skip to main content

What the FDA labels say about taking them together

Clarithromycin and thiotepa

Thiotepa's FDA label of January 30, 2026 names clarithromycin in its drug interactions section; the clarithromycin label PlainMeds reads does not name thiotepa. The thiotepa label: “Avoid co-administration of strong CYP3A4 inhibitors and strong CYP3A4 inducers with TEPADINA due to the potential effects on efficacy and toxicity.”

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the thiotepa FDA label on DailyMed (effective January 30, 2026, Amneal Pharmaceuticals LLC).

What does the clarithromycin label say about thiotepa?

Clarithromycin's label (effective April 9, 2026) does not name thiotepa in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the thiotepa label say about clarithromycin?

Thiotepa label, drug interactions

Avoid co-administration of strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, ritonavir) and strong CYP3A4 inducers (e.g., rifampin, phenytoin) with TEPADINA due to the potential effects on efficacy and toxicity [see Clinical Pharmacology ( 12.3 ) ].

Source: FDA drug label (TEPADINA), NDA208264 (Adienne Sa), as published by Amneal Pharmaceuticals LLC, effective January 30, 2026 (SPL set 559e353c-2dc0-16ba-e054-00144ff8d46c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
7Thiotepa generic labelers
ClarithromycinThiotepa
Labeled forBacterial infections, Acid reflux and ulcersOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?